Approaches for the discovery of new cell-penetrating peptides

被引:25
|
作者
Porosk, Ly [1 ]
Gaidutsik, Ilja [1 ]
Langel, Ulo [2 ]
机构
[1] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia
[2] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden
关键词
CPP; HTS; PTD; delivery vectors; CPP prediction; IN-VITRO; PREDICTION; SEQUENCE; NANOPARTICLES; BRAIN;
D O I
10.1080/17460441.2021.1851187
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The capability of cell-penetrating peptides (CPP), also known as protein transduction domains (PTD), to enter into cells possibly with an attached cargo, makes their application as delivery vectors or as direct therapeutics compelling. They are generally biocompatible, nontoxic, and easy to synthesize and modify. Three decades after the discovery of the first CPPs, similar to 2,000 CPP sequences have been identified, and many more predicted. Nevertheless, the field has a strong commitment to authenticate new, more efficient, and specific CPPs. Areas covered: Although a scattering of CPPs have been found by chance, various systematic approaches have been developed and refined over the years to directly aid the identification and depiction of new peptide-based delivery vectors or therapeutics. Here, the authors give an overview of CPPs, and review various approaches of discovering new ones. An emphasis is placed on in silico methods, as these have advanced rapidly in recent years. Expert opinion: Although there are many known CPPs, there is a need to find more efficient and specific CPPs. Several approaches are used to identify such sequences. The success of these approaches depends on the advancement of others and the successful prediction of CPP sequences relies on experimental data.
引用
收藏
页码:553 / 565
页数:13
相关论文
共 50 条
  • [41] Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer
    Bottens, Ryan A.
    Yamada, Tohru
    CANCERS, 2022, 14 (22)
  • [42] Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging
    Wang, Weiqin
    Abbad, Sarra
    Zhang, Zhenhai
    Wang, Shu
    Zhou, Jianping
    Lv, Huixia
    CURRENT CANCER DRUG TARGETS, 2015, 15 (04) : 337 - 351
  • [43] Perspectives and Challenges of Cell-Penetrating Peptides in Effective siRNA Delivery
    Yu, Zhiqiang
    Yu, Bin
    Kaye, Justin Boy
    Tang, Chenhong
    Chen, Shengxi
    Dong, Chenbo
    Shen, Bing
    NANO LIFE, 2014, 4 (04)
  • [44] In Vivo Targeting of Hydrogen Peroxide by Activatable Cell-Penetrating Peptides
    Weinstain, Roy
    Sayariar, Elamprakash N.
    Felsen, Csilla N.
    Tsien, Roger Y.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (03) : 874 - 877
  • [45] Identification of Uptake Mechanism of Cell-Penetrating Peptides by their Polar Profile
    Polanco, Carlos
    Samaniego Mendoza, Jose Lino
    Buhse, Thomas
    Castanon Gonzalez, Jorge Alberto
    Gimbel, Arturo
    Leopold Sordo, Marili
    CURRENT BIOINFORMATICS, 2015, 10 (05) : 586 - 598
  • [46] Cell-Penetrating Peptides: Nanocarrier for Macromolecule Delivery in Living Cells
    Chugh, Archana
    Eudes, Francois
    Shim, Youn-Seb
    IUBMB LIFE, 2010, 62 (03) : 183 - 193
  • [47] In silico approaches for designing highly effective cell penetrating peptides
    Gautam, Ankur
    Chaudhary, Kumardeep
    Kumar, Rahul
    Sharma, Arun
    Kapoor, Pallavi
    Tyagi, Atul
    Raghava, Gajendra P. S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [48] Cell-Penetrating Peptides-Mediated Therapeutic Agents Delivery into the Central Nervous System
    Wei, Yuanyuan
    Bao, Hongying
    Wang, Le
    Cao, Yi
    Liu, Zhusheng
    Zhu, Xueli
    Chen, Tianxiang
    Wu, Aiguo
    Li, Juan
    ACS MATERIALS LETTERS, 2024, 6 (06): : 2239 - 2258
  • [49] How to overcome endosomal entrapment of cell-penetrating peptides to release the therapeutic potential of peptides?
    Nadal-Bufi, Ferran
    Henriques, Sonia Troeira
    PEPTIDE SCIENCE, 2020, 112 (06)
  • [50] Recent advances of anti-cancer therapies including the use of cell-penetrating peptides
    Klimpel, Annika
    Luetzenburg, Tamara
    Neundorf, Ines
    CURRENT OPINION IN PHARMACOLOGY, 2019, 47 : 8 - 13